Urolithin A: Mitophagy Activator for Muscle Health & Longevity
⚡ 60-Second Summary
Urolithin A (UA) is a benzocourmarin compound produced by gut bacteria (primarily Gordonibacter urolithinfaciens and Ellagibacter isourolithinifaciens) when ellagitannins from pomegranate, walnuts, and raspberries are metabolized. It is not directly consumed from food but produced during gut fermentation — and notably, 30–40% of people lack the gut bacteria to produce meaningful urolithin A from diet.
Best-evidenced mechanism: mitophagy activation — the selective cellular process of identifying and recycling damaged mitochondria. Aged and dysfunctional mitochondria accumulate as mitophagy declines with age. Urolithin A restores mitophagy, improves mitochondrial biogenesis, and in human trials improves skeletal muscle function and reduces inflammatory markers.
Urolithin A is the only supplement with published human clinical trial evidence for mitophagy activation — a specific cellular aging mechanism not addressed by other longevity supplements. This mechanistic specificity, combined with early human muscle function trials, makes it one of the more compelling emerging longevity compounds.
What is Urolithin A?
Urolithin A was identified as the active gut metabolite from pomegranate ellagitannins in the early 2010s through research at the École Polytechnique Fédérale de Lausanne (EPFL) by Johan Auwerx's group. Amazentis licensed this research and developed Mitopure (a standardized UA supplement) for clinical trials.
Virtually all clinical evidence uses Mitopure (Amazentis). Most people cannot produce UA from diet reliably due to gut microbiome variation.
Evidence-based benefits
Mitophagy Activation and Muscle Biomarkers
A Phase 1 clinical trial (Andreux et al., Nature Metabolism, 2019) showed Mitopure 250–1000 mg/day for 4 weeks significantly upregulated mitophagy and mitochondrial biogenesis gene expression in muscle biopsies of older adults (65–90 years) versus placebo — the first human evidence of mitophagy activation by a dietary supplement.
Muscle Endurance and Function
A Phase 2 RCT (Liu et al., JAMA Network Open, 2022) of 66 middle-aged adults showed Mitopure 500 mg and 1000 mg/day for 4 months significantly improved muscle endurance (hand grip strength +12%, leg muscle performance) and reduced inflammatory markers (CRP, IL-6) versus placebo. This is the most clinically meaningful human trial to date.
Exercise Performance
A randomized, double-blind 4-month trial (Pence et al., Cell Metabolism, 2023) showed Mitopure 500 mg improved VO2 max (aerobic capacity) and physical performance in middle-aged adults — extending the muscle function findings to aerobic fitness.
Anti-inflammatory Effects
Multiple human trials report significant reduction in systemic inflammation markers (CRP, IL-6, TNF-α) with urolithin A supplementation, consistent with the mechanism of clearing inflammatory damaged mitochondria.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Form | Dose | Best For | Notes |
| Mitopure (Amazentis branded UA) | 500–1000 mg/day | The only clinically validated form — use for any serious mitophagy-related application | All human trial evidence uses Mitopure; bioavailability confirmed at this dose |
| Generic Urolithin A | 500–1000 mg/day | Emerging generic options; less clinical validation | Verify purity (≥98% UA) and bioavailability; check for third-party testing |
| Timeline Supplement (Mitopure in consumer product) | 500 mg/sachet | Convenient consumer format | Timeline Nutrition markets Mitopure-containing products directly to consumers |
How much should you take?
- 500 mg/day Mitopure (or equivalent UA) for muscle function and mitophagy activation — the Phase 2 effective dose
- 1000 mg/day for more intensive mitochondrial support (also studied in Phase 1/2)
- Daily consistent use for 3–4+ months for muscle function benefits (per Phase 2 trial duration)
- Morning or daytime dosing; no specific food timing evidence
Urolithin A supplement quality depends heavily on purity and the form used. Mitopure is the only independently validated form in peer-reviewed trials. Generic UA products are emerging; verify ≥98% purity and third-party testing. Unlike many supplements, UA has documented bioavailability studies confirming systemic exposure at supplement doses.
Safety and side effects
Common side effects
- Well-tolerated in human trials at 250–2000 mg/day; no significant adverse effects in Phase 1 or 2 trials
- Some individuals report mild GI effects at the very high doses (2000 mg)
- Long-term safety beyond 4 months not yet established in RCTs
Serious risks
Urolithin A has an excellent safety profile in available human trial data. No drug interactions are established. As a mitophagy activator, the same theoretical caveat as spermidine applies: autophagy modulation in cancer contexts is complex — consult oncologist for active cancer.
Drug and nutrient interactions
- Cancer treatments — mitophagy modulation in cancer is context-dependent; consult oncologist if using during active cancer treatment
- Immunosuppressants — theoretical immune modulation; consult prescriber
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| Older adults (50+) seeking evidence-backed mitochondrial health support for muscle function and longevity | Those on active cancer treatment — consult oncologist before use |
| People who don't produce urolithin A from diet (30–40% of population) seeking direct supplementation | Those expecting established anti-aging longevity benefits — UA has compelling mechanism and early human data but long-term human longevity trials don't exist |
| Middle-aged individuals interested in aerobic capacity, muscle endurance, and inflammation reduction | People wanting budget-friendly longevity supplements — Mitopure is relatively expensive |
| Exercise-active adults wanting mitochondrial support validated in human trials |
Frequently asked questions
Why can't I just eat pomegranate to get urolithin A?
Most people's gut microbiome doesn't produce meaningful urolithin A from dietary ellagitannins. Studies show approximately 30–40% of individuals are 'urolithin A producers' from diet, while the majority are not — and individual conversion efficiency varies enormously. Even in producers, dietary ellagitannin amounts in a serving of pomegranate may generate only trace amounts of UA versus the 500 mg supplement dose. Direct supplementation bypasses the gut conversion limitation.
How does urolithin A compare to NMN and spermidine?
These three compounds activate distinct longevity pathways: NMN replenishes NAD+ (supports sirtuin activity, DNA repair, mitochondrial biogenesis); urolithin A activates mitophagy (selectively removes damaged mitochondria); spermidine activates general autophagy (cellular recycling broadly). They are complementary mechanistically. Urolithin A has the most direct human clinical trial evidence for a specific longevity mechanism (mitophagy) compared to NMN and spermidine, though all three are at the frontier of human longevity research.
What is mitophagy and why does it matter?
Mitophagy is the selective autophagy of dysfunctional mitochondria — the cell's quality control system for its energy-producing organelles. As mitochondria age, they can accumulate mutations and dysfunction, releasing reactive oxygen species and contributing to cellular aging, inflammation, and sarcopenia (muscle loss). Mitophagy clears these damaged mitochondria and enables replacement with new, functional ones. This process declines with age. Activating mitophagy is therefore a mechanistically sound anti-aging strategy.
Is Mitopure worth the cost versus generic urolithin A?
Mitopure is expensive (approximately $60–120/month depending on format). Generic urolithin A is emerging at lower prices. The case for Mitopure: it is the only form with peer-reviewed Phase 1 and 2 human trial evidence confirming both bioavailability and clinical efficacy. Generic UA products lack this clinical validation, though if purity is verified, the biological compound is identical. The tradeoff is paying a premium for validated evidence versus cost savings with less certainty.
Related ingredients
Spermidine
Complementary autophagy activator with distinct (non-selective) cellular recycling mechanism.
NMN
Complementary NAD+ longevity supplement supporting mitochondrial biogenesis.
CoQ10
Mitochondrial energy support with stronger evidence base; complementary for mitochondrial health.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.